Botulinum Toxin Market Analysis By Type (Botulinum Toxin Type A, Botulinum Toxin Type B), By End Use (Therapeutic, Aesthetic), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2013 - 2025

Published: Jan, 2017 | Pages: 90 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global botulinum toxin (BNT) market is expected to reach a value of USD 7.3 billion by 2025. The constant introduction of innovative products for enhancement of aesthetic appeal supporting minimally invasive aesthetic treatments is the prime factor driving the growth of the market.

In addition, rapid growth of the sector is attributed to the rising demand for minimally invasive or non-invasive procedures. These procedures provide advantages such as small incision, shorter hospital stay and rapid wound healing, and hence lead to larger acceptance and demand. In addition, availability of wide variety of minimally invasive or non-invasive treatment options is pushing the global botulinum toxin market towards growth.

Also, the successful completion of research projects is expected to expand the applications of presently approved products. Companies are trying to widen the application of botulinum toxin in therapeutic area through various research activities. For instance, Botox by Allergan received the U.S. FDA approval for the treatment of strabismus (crossed eyes) and blepharospasm associated with dystonia in 1989. Furthermore, in 2004, Botox was approved by the U.S. FDA for hyperidrosis, cervical dystonia, upper limb spasticity, chronic migraine and urinary incontinence in 2009, 2010 and 2011 respectively. Hence, these factors all together will aid in boosting the growth of BNT sales during the forecast period.

Further Key Findings From the Study Suggest:

The rapid adoption of minimally invasive treatment is augmenting the growth of neurotoxins market.

The botulinum toxin type A segment accounted for the largest share in 2015 and is also anticipated to be the fastest growing segment during the forecast period

In 2015, North America dominated the global space with the largest revenue share owing to high demand for minimally invasive or non-invasive aesthetic treatments

Asia Pacific is expected to emerge as the fastest growing region during the forecast period, mainly due to growing social awareness regarding anti-wrinkle procedures in India, China, and Japan

Major players competing in this market include but are not limited to Allergan, Inc.; Ipsen Group; Merz GmbH and Co. KGaA, Medytox,Inc.; US Worldmed, LLC; Lanzhou Institute of Biological Products. Co.Ltd. and Revance Therapeutics, Inc.

 Table of Contents

Chapter 1 Research Methodology
                    1.1 Information procurement
                    1.2 Data Analysis
                    1.3 Approaches for market estimation
                         1.3.1 Approach 1: Demand analysis & bottom up approach
                         1.3.2 Approach 2: Top down market estimation
                         1.3.3 Approach 3: Commodity flow and bottom up market estimation
                         1.3.4 Approach 4: KoL perspective based market sizing
Chapter 2 Executive Summary
                    2.1 Market Snapshot
Chapter 3 Botulinum Toxin Market Variables, Trends & Scope
                    3.1 Market segmentation & scope
                    3.2 Market Driver Analysis
                         3.2.1 Growing population aging between 25 to 65 years of age
                         3.2.2 Rising demand for minimally invasive treatment
                         3.2.3 Expanding therapeutic use of botulinum toxin
                    3.3 Market Restraints Analysis
                         3.3.1 Risk of side effects 
                         3.3.2 Limited reimbursement coverage
                         3.3.3 Misuse as bioterrorism
                    3.4 Penetration & growth prospect mapping
                    3.5 Botulinum Toxin - SWOT Analysis, By Factor (political & legal, economic and technological)
                    3.6 Industry Analysis - Porter's
Chapter 4 Botulinum Toxin Market: Product Type Estimates & Trend Analysis
                    4.1 Botulinum Toxin Market: Product Type movement analysis
                    4.2 Botulinum Toxin Type A
                         4.2.1 Market estimates and forecast, 2013 - 2025 (USD Million)
                    4.3 Botox
                         4.3.1 Market estimates and forecast, 2013 - 2025 (USD Million)
                    4.4 Dysport
                         4.4.1 Market estimates and forecast, 2013 - 2025 (USD Million)
                    4.5 Xeomin
                         4.5.1 Market estimates and forecast, 2013 - 2025 (USD Million)
                    4.6 Others
                         4.6.1 Market estimates and forecast, 2013 - 2025 (USD Million)
                    4.7 Botulinum Toxin Type B
                         4.7.1 Market estimates and forecast, 2013 - 2025 (USD Million)
Chapter 5 Botulinum Toxin Market: End Use Estimates & Trend Analysis
                    5.1 Botulinum Toxin Market: End use movement analysis
                    5.2 Therapeutic Use
                         5.2.1 Market estimates and forecast, 2013 - 2025 (USD Million)
                    5.3 Aesthetic Use
                         5.3.1 Market estimates and forecast, 2013 - 2025 (USD Million)
Chapter 6 Botulinum Toxin Market: Regional Estimates &Trend Analysis, by Product Type & End Use
                    6.1 North America
                         6.1.1 U.S.
                              6.1.1.1 Market estimates and forecast, by product type 2013 - 2025 (USD Million)
                              6.1.1.2 Market estimates and forecast, by end use, 2013 - 2025 (USD Million)
                         6.1.2 Canada
                              6.1.2.1 Market estimates and forecast, by product type 2013 - 2025 (USD Million)
                              6.1.2.2 Market estimates and forecast, by end use, 2013 - 2025 (USD Million)
                    6.2 Europe
                         6.2.1 U.K.
                              6.2.1.1 Market estimates and forecast, by product type 2013 - 2025 (USD Million)
                              6.2.1.2 Market estimates and forecast, by end use, 2013 - 2025 (USD Million)
                         6.2.2 Germany
                              6.2.2.1 Market estimates and forecast, by product type 2013 - 2025 (USD Million)
                              6.2.2.2 Market estimates and forecast, by end use, 2013 - 2025 (USD Million)
                    6.3 Asia Pacific
                         6.3.1 Japan
                              6.3.1.1 Market estimates and forecast, by product type 2013 - 2025 (USD Million)
                              6.3.1.2 Market estimates and forecast, by end use, 2013 - 2025 (USD Million)
                         6.3.2 China
                              6.3.2.1 Market estimates and forecast, by product type 2013 - 2025 (USD Million)
                              6.3.2.2 Market estimates and forecast, by end use, 2013 - 2025 (USD Million)
                    6.4 Latin America
                         6.4.1 Brazil
                              6.4.1.1 Market estimates and forecast, by product type 2013 - 2025 (USD Million)
                              6.4.1.2 Market estimates and forecast, by end use, 2013 - 2025 (USD Million)
                         6.4.2 Mexico
                              6.4.2.1 Market estimates and forecast, by product type 2013 - 2025 (USD Million)
                              6.4.2.2 Market estimates and forecast, by end use, 2013 - 2025 (USD Million)
                    6.5 Middle East and Africa (MEA)
                         6.5.1 South Africa
                              6.5.1.1 Market estimates and forecast, by product type 2013 - 2025 (USD Million)
                              6.5.1.2 Market estimates and forecast, by end use, 2013 - 2025 (USD Million)
Chapter 7 Competitive Landscape
                    7.1 Ipsen group
                         7.1.1 Company Overview
                         7.1.2 Financial Performance
                         7.1.3 Product Benchmarking
                         7.1.4 Strategic Initiatives
                    7.2 Allergan Inc.
                         7.2.1 Company Overview
                         7.2.2 Financial Performance
                         7.2.3 Product Benchmarking
                         7.2.4 Strategic Initiatives
                    7.3 Medytox Inc.
                         7.3.1 Company Overview
                         7.3.2 Financial Performance
                         7.3.3 Product Benchmarking
                         7.3.4 Strategic Initiatives
                    7.4 Merz GmbH and Co. KGaA
                         7.4.1 Company Overview
                         7.4.2 Financial Performance
                         7.4.3 Product Benchmarking
                         7.4.4 Strategic Initiatives
                    7.5 US Worldmed, LLC
                         7.5.1 Company Overview
                         7.5.2 Financial Performance
                         7.5.3 Product Benchmarking
                         7.5.4 Strategic Initiatives
                    7.6 Lanzhou Institute of Biological Products Co. Ltd.
                         7.6.1 Company Overview
                         7.6.2 Financial Performance
                         7.6.3 Product Benchmarking
                         7.6.4 Strategic Initiatives
                    7.7 Revance Therapeutics, Inc.
                         7.7.1 Company Overview
                         7.7.2 Financial Performance
                         7.7.3 Product Benchmarking
                         7.7.4 Strategic Initiatives

List of Tables

TABLE 1 North America Botulinum Toxin Market, By Product Type, 2013 - 2025 (USD Million)
TABLE 2 North America Botulinum Toxin Market, By Type A, 2013 - 2025 (USD Million)
TABLE 3 North America Botulinum Toxin, By End Use, 2013 - 2025 (USD Million)
TABLE 4 U.S. Botulinum Toxin Market, By Product Type, 2013 - 2025 (USD Million)
TABLE 5 U.S. Botulinum Toxin Market, By Type A, 2013 - 2025 (USD Million)
TABLE 6 U.S. Botulinum Toxin, By End Use, 2013 - 2025 (USD Million)
TABLE 7 Canada Botulinum Toxin Market, By Product Type, 2013 - 2025 (USD Million)
TABLE 8 Canada Botulinum Toxin Market, By Type A, 2013 - 2025 (USD Million)
TABLE 9 Canada Botulinum Toxin, By End Use, 2013 - 2025 (USD Million)
TABLE 10 Europe Botulinum Toxin Market, By Product Type, 2013 - 2025 (USD Million)
TABLE 11 Europe Botulinum Toxin Market, By Type A, 2013 - 2025 (USD Million)
TABLE 12 Europe Botulinum Toxin, By End Use, 2013 - 2025 (USD Million)
TABLE 13 U.K. Botulinum Toxin Market, By Product Type, 2013 - 2025 (USD Million)
TABLE 14 U.K. Botulinum Toxin Market, By Type A, 2013 - 2025 (USD Million)
TABLE 15 U.K. Botulinum Toxin, By End Use, 2013 - 2025 (USD Million)
TABLE 16 Germany Botulinum Toxin Market, By Product Type, 2013 - 2025 (USD Million)
TABLE 17 Germany Botulinum Toxin Market, By Type A, 2013 - 2025 (USD Million)
TABLE 18 Germany Botulinum Toxin, By End Use, 2013 - 2025 (USD Million)
TABLE 19 Asia Pacific Botulinum Toxin Market, By Product Type, 2013 - 2025 (USD Million)
TABLE 20 Asia Pacific Botulinum Toxin Market, By Type A, 2013 - 2025 (USD Million)
TABLE 21 Asia Pacific Botulinum Toxin, By End Use, 2013 - 2025 (USD Million)
TABLE 22 Japan Botulinum Toxin Market, By Product Type, 2013 - 2025 (USD Million)
TABLE 23 Japan Botulinum Toxin Market, By Type A, 2013 - 2025 (USD Million)
TABLE 24 Japan Botulinum Toxin, By End Use, 2013 - 2025 (USD Million)
TABLE 25 China Botulinum Toxin Market, By Product Type, 2013 - 2025 (USD Million)
TABLE 26 China Botulinum Toxin Market, By Type A, 2013 - 2025 (USD Million)
TABLE 27 China Botulinum Toxin, By End Use, 2013 - 2025 (USD Million)
TABLE 28 Latin America Botulinum Toxin Market, By Product Type, 2013 - 2025 (USD Million)
TABLE 29 Latin America Botulinum Toxin Market, By Type A, 2013 - 2025 (USD Million)
TABLE 30 Latin America Botulinum Toxin, By End Use, 2013 - 2025 (USD Million)
TABLE 31 Brazil Botulinum Toxin Market, By Product Type, 2013 - 2025 (USD Million)
TABLE 32 Brazil Botulinum Toxin Market, By Type A, 2013 - 2025 (USD Million)
TABLE 33 Brazil Botulinum Toxin, By End Use, 2013 - 2025 (USD Million)
TABLE 34 Mexico Botulinum Toxin Market, By Product Type, 2013 - 2025 (USD Million)
TABLE 35 Mexico Botulinum Toxin Market, By Type A, 2013 - 2025 (USD Million)
TABLE 36 Mexico Botulinum Toxin, By End Use, 2013 - 2025 (USD Million)
TABLE 37 MEA Botulinum Toxin Market, By Product Type, 2013 - 2025 (USD Million)
TABLE 38 MEA Botulinum Toxin Market, By Type A, 2013 - 2025 (USD Million)
TABLE 39 MEA Botulinum Toxin, By End Use, 2013 - 2025 (USD Million)
TABLE 40 South Africa Botulinum Toxin Market, By Product Type, 2013 - 2025 (USD Million)
TABLE 41 South Africa Botulinum Toxin Market, By Type A, 2013 - 2025 (USD Million)
TABLE 42 South Africa Botulinum Toxin, By End Use, 2013 - 2025 (USD Million)